Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer

NCT00590109 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT00590109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00590109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Germline BRCA1 and BRCA2 Mutations in Jewish Women Affected by Breast Cancer
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Observational
Overall status
Completed
Start date
March 31, 1997
Completion date
December 22, 2021
Enrollment
383 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer